This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Arkansas. Active years: 2015-2024.
Company Filing History:
Years Active: 2015-2024
Title: Amanda Wolfenden: Innovator in Mucosal Adjuvants and Delivery Systems
Introduction
Amanda Wolfenden is a prominent inventor based in Pea Ridge, Arkansas. She has made significant contributions to the field of vaccine development through her innovative work on mucosal adjuvants and delivery systems. With a total of 4 patents, her research focuses on enhancing immune responses in subjects.
Latest Patents
Wolfenden's latest patents include groundbreaking work on adjuvants comprising chitosan cross-linked with an aldehyde or mannosylated chitosan. These patents detail methods for creating these adjuvants and combining them with antigens. The resulting adjuvant-antigen combinations are designed for use in vaccine formulations, which can effectively vaccinate animals against specific antigens or enhance immune responses.
Career Highlights
Amanda Wolfenden is affiliated with the University of Arkansas, where she continues her research and development in the field of immunology. Her work has garnered attention for its potential applications in veterinary medicine and beyond.
Collaborations
Wolfenden collaborates with notable colleagues, including Billy M Hargis and Neil R Pumford, who contribute to her research endeavors.
Conclusion
Amanda Wolfenden's innovative work in mucosal adjuvants and delivery systems positions her as a key figure in vaccine research. Her contributions are paving the way for advancements in immunology and animal health.